期刊文献+
共找到24篇文章
< 1 2 >
每页显示 20 50 100
In Vitro Study on Virulence Potentials of Burkholderia pseudomallei Isolated from Immunocompromised Patients
1
作者 Hadeel Tawfiq Al-Hadithi Rana Muhammad Abdulnabi 《Journal of Life Sciences》 2012年第10期1109-1116,共8页
Eighty four throat swabs were obtained from Basrah General Hospital inpatients (N = 34): 17 were suffering from renal failure and the other 17 were diabetics; and from outpatients (N = 50). Throat swabs were cult... Eighty four throat swabs were obtained from Basrah General Hospital inpatients (N = 34): 17 were suffering from renal failure and the other 17 were diabetics; and from outpatients (N = 50). Throat swabs were cultured first in the selective media Ashdown's broth then subcultured on Ashdown's agar to isolate Burkholderia pseudomallei which was recovered from seven cases (8.33%). Four isolates were from renal failure patients (23.53%), two from diabetic patients (11.76%) and the seventh isolate was from an outpatient with tonsillitis. All isolates were able to produce capsules, form filament chains, exhibit swarming motility and were arabinose non assimilators (Ara-) indicative of their virulence. Additionally, isolated B. pseudomallei were found to produce protease, lipase, hemolysin, and lecithinase and were able to produce biofilm, the root of many troublesome persistent infections that resist antibiotic treatment. Susceptibility of the seven isolates of B. pseudomallei toward 11 antibiotics was assessed, isolates were found multiply resistant to all antibiotics apart from ciproflaxin. This study confirms for the first time isolation of B. pseudomallei from immunocompromised patients in Basrah city of Iraq and describes their virulence potentials. 展开更多
关键词 B. pseudomallei virulence potentials BIOFILM antibiotic susceptibility immunocompromised patients.
在线阅读 下载PDF
Clinical characteristics of immunocompromised patients infected with COVID-19
2
作者 LI Shengnan 《China Medical Abstracts(Internal Medicine)》 2025年第2期87-88,共2页
Objective To analyze the clinical featuresof COVID-19 infection in hospitalized immunocompromised patients in comparison with immunocompetent patients.Methods A single-center retrospective observational study was cond... Objective To analyze the clinical featuresof COVID-19 infection in hospitalized immunocompromised patients in comparison with immunocompetent patients.Methods A single-center retrospective observational study was conducted on 213 inpatients diagnosed with COVID-19 in the Peking University People's Hospital between December 2022 and October 2023.They were divided into an immunocompromised group(102 patients,47.9%)and an immunocompetent group(111 patients,52.1%),and clinical data were compared between the two groups.The immunocompromised group was further divided into death group(18 cases,17.6%)and nondeath group(84 cases,82.4%).The differences in laboratory examination findings were compared.Further analysis was performed on the lymphocyte subset differences between the death group(10 patients,9.8%)and the non-death group(36 patients,35.3%)with complete data.Results The proportion of severe and critical cases and the mortality rate,were significantly higher in the immunocompromised group than the immunocompetent group(47.1%vs.40.5%,18.6%vs.9.0%,17.6%us.9.0%,P<0.05).The immunocompromised group had lower vaccination rate(26.5%vs.44.1%,P<0.05).Hypertension,kidney disease and infections were more common in the immunocompromised group(63.7%us.48.6%,30.4%us.9.0%,49.0%vs.19.8%,all P<0.05).CT findings of consolidation(40.2%us.18.9%),rate of antiviral treatment(48.0%vs.30.6%)and the positive duration of viral nucleic acid[median 14(7.0,19.3)days us.9(7.0,18.0)days]were higher in the immunocomprised group(all P<0.05).Lactate dehydrogenase(LDH),Fprocalcitonin(PCT),interleukin-6(IL-6)and ferritin were higher in the immunocompromised group thanthose inthe immunocompetent group(all P<0.05).In the death group,neutrophils(NEU),C-reactive protein(CRP),PCT,IL-6,ferritin and D-dimer were higher,while lymphocytes(LY),CD4^(+)T-cells,CD8^(+)T-cells,B-cell counts and hemoglobin(HGB)were significantly lower than those in the non-death group(all P<0.05).Conclusion More than 60%of patients in the immunocompromised group are classified as severoe r critical type,with a higher mortality rate and decreased ability to clear severe acuterespiratorySsyndrome coronavirus 2(SARS-CoV-2).Decreasesintotal lymphocytes,CD4^(+)T lymphocytes,CD8^(+)T lymphocytes,and B lymphocytes,along with elevated levels of procalcitonin,ferritin,and D-dimer,indicate poor prognosis. 展开更多
关键词 Laboratory Examination Retrospective Study Hospitalized patients Clinical Features Immunocompetent patients immunocompromised patients immunocompromised patients COVID
原文传递
Histoplasmosis misdiagnosed as malignancies in immunocompetent and immunocompromised patients 被引量:1
3
作者 Ofonime E.Benjamin Thelma E.Bassey +5 位作者 Chimaobi I.Nwagboso Asukwo Onukak Anthony C.Nlemadim Bernard B.Akpu David Elem Bassey E.Ekeng 《hLife》 2025年第8期386-390,共5页
Histoplasmosis is a serious fungal disease commonly reported in the Americas,Southeast Asia,and sub-Saharan Africa[1].The classical or American type is caused by Histoplasma capsulatum var.capsulatum while African his... Histoplasmosis is a serious fungal disease commonly reported in the Americas,Southeast Asia,and sub-Saharan Africa[1].The classical or American type is caused by Histoplasma capsulatum var.capsulatum while African histoplasmosis is caused by H.capsulatum var.duboisii[2]. 展开更多
关键词 histoplasma capsulatum MISDIAGNOSIS immunocompromised patients HISTOPLASMOSIS MALIGNANCIES immunocompetent patients
暂未订购
Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immunocompromised patients: a meta-analysis 被引量:7
4
作者 Hanssa Summah ZHU Ying-gang +2 位作者 Matthew E Falagas Evridiki K Vouloumanou QU Jie-ming 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第10期1965-1973,共9页
Background The diagnosis of Pneumocystis pneumonia (PCP) in immunocompromised patients is still challenging today due to the absence of an in vitro culture system and the low diagnostic accuracy of microscopic exami... Background The diagnosis of Pneumocystis pneumonia (PCP) in immunocompromised patients is still challenging today due to the absence of an in vitro culture system and the low diagnostic accuracy of microscopic examinations. Herein, we performed a meta-analysis to evaluate the accuracy of real-time polymerase chain reaction (PCR) in the diagnosis of PCP. Methods We searched Web of Knowledge and Medline from 1990 to May 2010 for studies reporting diagnostic accuracy data regarding the use of real-time PCR in the diagnosis of PCP in immunocompromised patients. Results Ten individual studies were included. Overall, the sensitivity of real-time PCR was 97% (95% CI: 93%-99%); the specificity was 94% (95% CI: 90%-96%). The area under the HSROC curve (95% CO for real-time PCR was 0.99 (0.97-0.99). In a subgroup analysis regarding studies involving HIV patients among the study population, the sensitivity and specificity were 97% (95% CI: 93%-99%) and 93% (95% CI: 89%-96%), respectively. Regarding studies using Bronchoalveolar lavage (BAL) samples only: sensitivity =98% (95% CI: 94%-99%); specificity =93% (95% CI: 89%- 96%), respectively. Regarding studies using microscopy as a reference standard: sensitivity =97% (95% CI: 92%-99%); specificity =93% (95% CI: 88%-96%). However, high between-study statistical heterogeneity was observed in all analyses. Conclusions Real-time PCR has a good diagnostic accuracy and may provide a useful adjunctive tool for the diagnosis of PCP in immunocompromised patients. Further studies are needed in order to identify any differences in the diagnostic performance of real-time PCR in HIV and non-HIV immunocompromised patients. 展开更多
关键词 real-time polymerase chain reaction Pneumocystis pneumonia non-HIV immunocompromised patients HIV-positive
原文传递
Altered CD8+ T-cell counts as an early predictor of prognosis in critically ill immunocompromised patients with invasive pulmonary aspergillosis 被引量:3
5
作者 Cui Na Wang Hao Long Yun Liu Dawei 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第1期36-42,共7页
Background The number of critically ill immunocompromised (CIIC) patients has increased dramatically in recent years,and they represent a high risk population for invasive pulmonary aspergillosis (IPA) infection.H... Background The number of critically ill immunocompromised (CIIC) patients has increased dramatically in recent years,and they represent a high risk population for invasive pulmonary aspergillosis (IPA) infection.Host immunity should play a major role in determining the outcome and recovery of these patients.The purpose of this study was to evaluate the dynamic changes in host immune status and its potential influence on prognosis in CIIC patients with IPA.Methods We monitored the evolution of a number of key cellular and humoral parameters on days 1,3,and 10 (D1,D3 and D10) following ICU admission in sixty-two CIIC patients with microbiological evidence of IPA.We included immunoglobulins IgG,IgA and IgM,complement factors C3 and C4,and lymphocyte subgroups CD3+,CD4+,CD8+,CD28+CD4+,and CD28+CD8+ T cells,CD19+B cells,and CD3-CD16+CD56+ natural killer cells (NK).Results The primary outcome was 28-day mortality.Thirty-eight (61.3%) patients died within the 28 days following ICU admission.Compared to patients who died,CD3+,CD8+,CD28+CD8+ T-cell counts on D1,D3,and D10,CD28+CD4+ T-cell counts on D3 and D10,and NK counts on D3 and D10 were significantly higher in survivors.Receiver operating characteristic (ROC) analysis of immune parameters predicting 28-day mortality revealed area under the curve (AUC) values of 0.82 (95% CI 0.71-0.92),0.94 (95% CI 0.87-0.99),and 0.94 (95% CI 0.85-0.99) for CD8+ T-cell counts for D1,D3,and D10 respectively,and 0.84 (95% CI 0.75-0.94),0.92 (95% CI 0.85-0.99),and 0.90 (95% CI 0.79-0.99) for CD28+CD8+ T-cell counts for D1,D3,and D10 respectively.Kaplan-Meier survival analysis showed that CD8+ T-cell counts <149.5×106 cells/L and CD28+CD8+ T-cell counts <75×106 cells/L at ICU admission were associated with lower survival probabilities in CIIC patients with IPA (both Log rank:P<0.001).Conclusions Low CD8+ and CD28+CD8+ T-cell counts were associated with high mortality in CIIC patients with IPA.Early counts of CD8+ and CD28+CD8+ T cells in CIIC patients with IPA may be valuable for predicting outcome. 展开更多
关键词 immunocompromised patients critical illness invasive pulmonary aspergillosis CD8-positive T-lymphocytes
原文传递
Spontaneous remission of Pneumocystisjiroveci pneumonia in 2 non-AIDS immunocompromised patients
6
作者 MU Xiang-dong WANG Guang-fa MA Jing ZHANG Cheng SU Li CHEN Jian 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第1期184-185,共2页
Pneumocystis jiroveci (P. jiroveci) pneumonia (PCP) in non-AIDS immunocompromised patients ismuch more critical than that in AIDS patients,1 Without treatment, mortality of PCP in immunocompromised patients approa... Pneumocystis jiroveci (P. jiroveci) pneumonia (PCP) in non-AIDS immunocompromised patients ismuch more critical than that in AIDS patients,1 Without treatment, mortality of PCP in immunocompromised patients approaches 100 percent, and there were no reports of spontaneous remissions of PCP without anti-PCP therapy.2 Here we report 2 non-AIDS immunocompromised patients in whom PCP developed and remitted without treatment. 展开更多
关键词 Pneumocystis jiroveci pneumonia non-AIDS immunocompromised patients spontaneous remission
原文传递
COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
7
作者 Zilu Zhang Jingtao Huang +6 位作者 Luxiang Wang Zengkai Pan Jiayu Huang Chuanhe Jiang Sujiang Zhang Su Li Xiaoxia Hu 《Blood Science》 2024年第2期45-52,共8页
Data on severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection in patients at early stage of immune reconstitution after hematopoietic stem cell transplantation(HSCT)are limited.In the present study,we r... Data on severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection in patients at early stage of immune reconstitution after hematopoietic stem cell transplantation(HSCT)are limited.In the present study,we retrospectively investigated the incidence and clinical features of SARS-CoV-2 infection in patients who underwent HSCT in 2022.Patients(allo-HSCT,n=80;auto-HSCT,n=37)were consecutively included in the study.The SARS-CoV-2 infection rate was 59.8%,and the median interval of HSCT to coronavirus disease 2019(COVID-19)was 4.8(range:0.5–12)months.Most patients were categorized as mild(41.4%)or moderate(38.6%),and 20%as severe/critical.No deaths were attributable to COVID-19.Further analysis showed that lower circulating CD8^(+)T-cell counts and calcineurin inhibitor administration increased the risk of SARS-CoV-2 infection.Exposure to rituximab significantly increased the probability of severe or critical COVID-19 compared with that of mild/moderate illness(P<.001).In the multivariate analysis,rituximab use was associated with severe COVID-19.Additionally,COVID-19 had no significant effect on immune reconstitution.Furthermore,it was found that Epstein–Barr virus infection and rituximab administration possibly increase the risk of developing severe illness.Our study provides preliminary insights into the effect of SARS-CoV-2 on immune reconstitution and the outcomes of allo-HSCT recipients. 展开更多
关键词 Hematopoietic stem cell transplantation Immune reconstitution immunocompromised patients Severe acute respiratory syndrome coronavirus 2
原文传递
A comparative study of clinical manifestations caused by tuberculosis in immunocompromised and non-immunocompromised patients
8
作者 邵长周 瞿介明 何礼贤 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第11期1717-1722,共6页
Objective To characterize the differences between clinical manifestations in immunocompromised patients (ICPs) and non-immunocompromised patients (non-ICPs) with tuberculosis.Methods Underlying diseases, clinical pres... Objective To characterize the differences between clinical manifestations in immunocompromised patients (ICPs) and non-immunocompromised patients (non-ICPs) with tuberculosis.Methods Underlying diseases, clinical presentations, misdiagnosis, treatment and prognosis, etc, were analyzed retrospectively in 115 tuberculosis patients, including 39 ICPs and 76 non-ICPs.Results Compared with non-ICPs, the individuals who were ICP had more expectoration (64.1 % vs 35. 5%), pulmonary moist rale (41. 0% vs 9. 2%), miliary pulmonary tuberculosis (30. 8% vs 2. 6%), pleural effusion (48. 7% vs 25. 0%) and lymphadenopathy (18. 0% vs 4. 0 %). ICPs had less lung cavity (15. 4% vs 22. 4%) and pleural thickening (15. 4% vs 23. 7%) compared to non-ICPs. Pulmonary tuberculosis in ICPs was prone to be misdiagnosed as pneumonia (23.1 % vs 6. 6%). Pulmonary tuberculosis was found in the apicoposterior segment (SⅠ+SⅡ) in more cases in non-ICPs (21.7%, 10/46) than ICPs (10.3%, 3/29). The diagnostic value of tuberculin skin test and adenosine deaminase in pleural effusions was limited in ICPs. ICPs had significantly poorer prognoses than non-ICPs.Conclusion The clinical manifestations of ICPs with tuberculosis are atypical, misdiagnosis often occurs, resulting in a worse prognosis. 展开更多
关键词 immunocompromised patient TUBERCULOSIS DIAGNOSIS DIFFERENTIAL
原文传递
Critical considerations for the management of acute abdomen in transplant patients 被引量:1
9
作者 Efstathios T Pavlidis Georgios Katsanos +3 位作者 Athanasios Kofinas Georgios Tsoulfas Ioannis N Galanis Theodoros E Pavlidis 《World Journal of Transplantation》 2024年第2期8-12,共5页
The number of solid organ transplantations performed annually is increasing and are increasing in the following order:Kidney,liver,heart,lung,pancreas,small bowel,and uterine transplants.However,the outcomes of transp... The number of solid organ transplantations performed annually is increasing and are increasing in the following order:Kidney,liver,heart,lung,pancreas,small bowel,and uterine transplants.However,the outcomes of transplants are impro-ving(organ survival>90%after the 1st year).Therefore,there is a high probability that a general surgeon will be faced with the management of a transplant patient with acute abdomen.Surgical problems in immunocompromised patients may not only include graft-related problems but also nongraft-related problems.The perioperative regulation of immunosuppression,the treatment of accompanying problems of immunosuppression,the administration of cortisol and,above all,the realization of a rapidly deteriorating situation and the accurate evaluation and interpretation of clinical manifestations are particularly important in these patients.The perioperative assessment and preparation includes evaluation of the patient’s cardiovascular system and determining if the patient has hypertension or suppression of the hypothalamic-pituitary-adrenal axis,or if the patient has had any coagulation mechanism abnormalities or thromboembolic episodes.Immunosuppression in transplant patients is associated with the use of calci-neurin inhibitors,corticosteroids,and antiproliferation agents.Many times,the clinical picture is atypical,resulting in delays in diagnosis and treatment and leading to increased morbidity and mortality.Multidetector computed tomo-graphy is of utmost importance for early diagnosis and management.Transplant recipients are prone to infections,especially specific infections caused by cytomegalovirus and Clostridium difficile,and they are predisposed to intraop-erative or postoperative complications that require great care and vigilance.It is necessary to follow evidence-based therapeutic protocols.Thus,it is required that the clinician choose the correct therapeutic plan for the patient(conservative,emergency open surgery or minimally invasive surgery,including laparoscopic or even robotic surgery). 展开更多
关键词 Acute abdomen Abdominal emergency surgery TRANSPLANTATION immunocompromised patients IMMUNO-SUPPRESSION Posttransplantation surgery
暂未订购
Impact of next-generation sequencing on antimicrobial treatment in immunocompromised adults with suspected infections
10
作者 Jia Li Jiazhen Luo +3 位作者 Tao Hu Ling Cheng Weiwei Shang Li Yan 《World Journal of Emergency Medicine》 SCIE CAS CSCD 2024年第2期105-110,共6页
BACKGROUND:Prompt pathogen identification can have a substantial impact on the optimization of antimicrobial treatment.The objective of the study was to assess the diagnostic value of next-generation sequencing(NGS)fo... BACKGROUND:Prompt pathogen identification can have a substantial impact on the optimization of antimicrobial treatment.The objective of the study was to assess the diagnostic value of next-generation sequencing(NGS)for identifying pathogen and its clinical impact on antimicrobial intervention in immunocompromised patients with suspected infections.METHODS:This was a retrospective study.Between January and August 2020,47 adult immunocompromised patients underwent NGS testing under the following clinical conditions:1)prolonged fever and negative conventional cultures;2)new-onset fever despite empiric antimicrobial treatment;and 3)afebrile with suspected infections on imaging.Clinical data,including conventional microbial test results and antimicrobial treatment before and after NGS,were collected.Data were analyzed according to documented changes in antimicrobial treatment(escalated,no change,or deescalated)after the NGS results.RESULTS:The median time from hospitalization to NGS sampling was 19 d.Clinically relevant pathogens were detected via NGS in 61.7% of patients(29/47),more than half of whom suffered from fungemia(n=17),resulting in an antimicrobial escalation in 53.2% of patients(25/47)and antimicrobial de-escalation in 0.2% of patients(1/47).Antimicrobial changes were mostly due to the identification of fastidious organisms such as Legionella,Pneumocystis jirovecii,and Candida.In the remaining three cases,NGS detected clinically relevant pathogens also detected by conventional cultures a few days later.The antimicrobial treatment was subsequently adjusted according to the susceptibility test results.Overall,NGS changed antimicrobial management in 55.3%(26/47)of patients,and conventional culture detected clinically relevant pathogens in 14.9% of the patients(7/47).CONCLUSION:With its rapid identification and high sensitivity,NGS could be a promising tool for identifying relevant pathogens and enabling rapid appropriate treatment in immunocompromised patients with suspected infections. 展开更多
关键词 immunocompromised patients Next-generation sequencing Antimicrobial management
暂未订购
Successively bilateral cytomegalovirus retinitis in immunocompromised patient with Good's syndrome 被引量:1
11
作者 Feng Hu Yuan Du Xiao-Yan Peng 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第12期2021-2023,共3页
Dear Editor,I am Dr. Feng Hu, from the Department of Ophthalmology of Beijing Tongren Hospital, Beijing, China. I write to present a case report of cytomegalovirus retinitis (CMVR) in Good’s syndrome (GS).GS is an ex... Dear Editor,I am Dr. Feng Hu, from the Department of Ophthalmology of Beijing Tongren Hospital, Beijing, China. I write to present a case report of cytomegalovirus retinitis (CMVR) in Good’s syndrome (GS).GS is an extremely rare primary immune-deficiency syndrome,which consists of simultaneous occurrence of 展开更多
关键词 In Successively bilateral cytomegalovirus retinitis in immunocompromised patient with Good’s syndrome FIGURE
原文传递
Chronic renal insufficiency complicated by skin infection with Nocardia brasiliensis:A case report 被引量:1
12
作者 Shan-Shan Zhang Ying Lu Wen-Ning Fu 《World Journal of Clinical Cases》 2025年第20期78-84,共7页
BACKGROUND Nocardiosis is a rare bacterial infection with unclear epidemiology,pathogenesis,and characteristics.Its clinical manifestations are diverse and nonspecific,making diagnosis prone to errors,including misdia... BACKGROUND Nocardiosis is a rare bacterial infection with unclear epidemiology,pathogenesis,and characteristics.Its clinical manifestations are diverse and nonspecific,making diagnosis prone to errors,including misdiagnosis and missed diagnosis.Additionally,this disease is difficult to treat,often requiring months or even years of antibacterial therapy,and can be fatal in patients with underlying conditions.CASE SUMMARY A 93-year-old male patient with chronic renal insufficiency sustained a skin injury at the tip of his right thumb.As a result of an initial misdiagnosis and inadequate treatment,the infection progressed,resulting in multiple rashes on his right upper limb.Local incision and drainage of pus,combined with oral antibiotics administered at a different hospital,yielded no significant improvement.Upon hospitalization,the patient’s immune function was assessed,and further local incision and drainage were performed.Cultures of the pus identified Nocardia brasiliensis.Treatment involved intravenous infusion of piperacillin-tazobactam sodium and oral administration of sulfamethoxazole-trimethoprim,leading to the patient’s recovery.After discharge,the patient continued to take sulfamethoxazole tablets for 6 months,with complete healing of the skin lesions and no recurrence.CONCLUSION Nocardiosis should be considered in patients with underlying conditions and compromised immunity.Prompt and accurate diagnosis is crucial. 展开更多
关键词 Cutaneous nocardiosis Nocardia brasiliensis Chronic renal insufficiency Skin infection immunocompromised patients Case report
暂未订购
Distinct tropisms of HCMV and SARS-CoV-2 in lung tissue of a patient with advanced HIV disease
13
作者 Jingjing Xu Bo Yang +5 位作者 Ye Zheng Yuexiang Yang Min-Hua Luo Yun Ling Xiaohong Fan Han Cheng 《Virologica Sinica》 2025年第1期141-143,共3页
Dear Editor,The COVID-19 pandemic,caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),has resulted in millions of deaths worldwide.It poses significant challenges in the management of immunocompr... Dear Editor,The COVID-19 pandemic,caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),has resulted in millions of deaths worldwide.It poses significant challenges in the management of immunocompromised patients,particularly people with HIV(PWH).Whether PWH are more vulnerable to COVID with more adverse outcomes has been extensively studied,but the findings are inconsistent.Many cohort studies and meta-analyses support that PWH have a higher risk of SARSCoV-2 infection and more severe COVID-19 outcomes(Bertagnolio et al.,2022;Ssentongo et al.,2021). 展开更多
关键词 immunocompromised patients severe acute respiratory syndrome coronavirus Lung tissue TROPISMS HCMV cohort studies SARS CoV HIV
原文传递
Chronic renal insufficiency and Nocardia brasiliensis infection:A call for heightened vigilance and multidisciplinary management
14
作者 Jing Ding Dan-Dan Shi Ju Tian 《World Journal of Clinical Cases》 2025年第24期104-109,共6页
This letter discusses the critical yet underrecognized intersection of chronic renal insufficiency and Nocardia brasiliensis skin infection in the case reported by Zhang et al,emphasizing the diagnostic challenges and... This letter discusses the critical yet underrecognized intersection of chronic renal insufficiency and Nocardia brasiliensis skin infection in the case reported by Zhang et al,emphasizing the diagnostic challenges and therapeutic complexities in the context of advanced age,comorbidities,and immunocompromised populations.The study’s strengths included its integration of immunological profiling and precision medicine,demonstrating that a tailored low-dose trimethoprimsulfamethoxazole regimen with pharmacokinetic monitoring can improve outcomes in geriatric patients with chronic renal insufficiency while mitigating nephrotoxicity risks.However,its limitations included a single-case design,reliance on phenotypic diagnostics,and the lack of information regarding comorbidity interactions.The findings support the use of advanced molecular tools for rapid pathogen identification and identification of co-infection.Future studies should prioritize elucidating the synergistic effects of chronic kidney disease-uremia and immunosuppression on Nocardia colonization,developing biomarkers for early detection,and conducting global epidemiological studies in endemic regions.This case underscores the importance of interdisciplinary collaboration and innovative diagnostics to optimize management of nocardiosis in vulnerable populations. 展开更多
关键词 Chronic renal insufficiency Nocardia brasiliensis Skin infection immunocompromised patients Multidisciplinary management
暂未订购
Hepatic flares in chronic hepatitis C: Spontaneous exacerbation vs hepatotropic viruses superinfection 被引量:4
15
作者 Evangelista Sagnelli Caterina Sagnelli +1 位作者 Mariantonietta Pisaturo Nicola Coppola 《World Journal of Gastroenterology》 SCIE CAS 2014年第22期6707-6715,共9页
The hepatitis C virus(HCV)causes an acute infection that is frequently asymptomatic,but a spontaneous eradication of HCV infection occurs only in one-third of patients.The remaining two-thirds develop a chronic infect... The hepatitis C virus(HCV)causes an acute infection that is frequently asymptomatic,but a spontaneous eradication of HCV infection occurs only in one-third of patients.The remaining two-thirds develop a chronic infection that,in most cases,shows an indolent course and a slow progression to the more advanced stagesof the illness.Nearly a quarter of cases with chronic hepatitis C(CHC)develop liver cirrhosis with or without hepatocellular carcinoma.The indolent course of the illness may be troubled by the occurrence of a hepatic flare,i.e.,a spontaneous acute exacerbation of CHC due to changes in the immune response,immunosuppression and subsequent restoration,and is characterized by an increase in serum aminotransferase values,a frequent deterioration in liver fibrosis and necroinflammation but also a high frequency of sustained viral response to pegylated interferon plus ribavirin treatment.A substantial increase in serum aminotransferase values during the clinical course of CHC may also be a consequence of a superinfection by other hepatotropic viruses,namely hepatitis B virus(HBV),HBV plus hepatitis D virus,hepatitis E virus,cytomegalovirus,particularly in geographical areas with high endemicity levels.The etiology of a hepatic flare in patients with CHC should always be defined to optimize follow-up procedures and clinical and therapeutic decisions. 展开更多
关键词 Chronic hepatitis C virus infection Hepatic flares Hepatic flares in immunocompromised patients immunocompromised patients Hepatitis A virus superinfection
暂未订购
Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients 被引量:24
16
作者 Xiang-Dong Mu Peng Jia +4 位作者 Li Gao Li Su Cheng Zhang Ren-Gui Wang Guang-Fa Wang 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第17期2020-2025,共6页
Background: Although radiological features ofpneumocystis pneumonia (PCP) in non-Acquired Immune Deficiency Syndrome (AIDS) immunocompromised patients have been reported by other authors, there were no studies on... Background: Although radiological features ofpneumocystis pneumonia (PCP) in non-Acquired Immune Deficiency Syndrome (AIDS) immunocompromised patients have been reported by other authors, there were no studies on the radiological stages of PCP previously. This study aimed to elucidate the radiological stages and prognoses of PCP in non-AIDS immunocompromised patients. Methods: Retrospective analysis ofradiological manifestations and prognoses of 105 non-AIDS PCP immunocompromised patients from August 2009 to April 2016 was conducted. Chest radiograph was divided into three stages: early stage (normal or nearly normal chest radiograph), mid stage (bilateral pulmonary infiltrates), and late stage (bilateral pulmonary consolidations); chest high-resolution computed tomography (HRCT) was also divided into three stages: early stage (bilateral diffuse ground-glass opacity [GGO]), mid stage (bilateral diffuse GGO and patchy consolidations), and late stage (bilateral diffuse consolidations). Results: The case fatality rate (CFR) of all patients was 34.3% (36/105), all of them took routine chest X-ray (CXR), and 84 underwent chest CT examinations. According to the CXR most near the beginning ofanti-PCP therapy, 18 cases were at early stage and CFR was 0 (0/18, P 〈 0.01), 50 cases were at mid stage and CFR was 28.0% (14/50, P〉 0.05), and 37 cases were at late stage and CFR was 59.5% (22/37, P 〈 0.01). According to the chest HRCT most near the beginning ofanti-PCP therapy, 40 cases were at early stage and CFR was 20.0% (8/40, P 〉 0.05), 34 cases were at mid stage and CFR was 47.1% (l 6/34, P 〉 0.05), and 10 cases were at late stage and CFR was 80.0% (8/10, P 〈 0.05); barotrauma, including pneumothorax, pneumomediastinum, and pneumohypoderma, was found in 18 cases and the CFR was 77.8% (14/18, P 〈 0.01). Conclusions: Based on the radiological manifestations, the course of PCP in non-A1DS immunocompromised patients can be divided into three stages: early stage, mid stage, and late stage. The prognoses of patients treated at early stage are good, and those at late stage are poor. Furthermore, the CFR of patients with barotrauma is high. 展开更多
关键词 immunocompromised patients Pneumocystis Pneumonia PROGNOSIS Radiological Stages
原文传递
Epidemiology of hepatitis E virus in Iran 被引量:1
17
作者 Reza Taherkhani Fatemeh Farshadpour 《World Journal of Gastroenterology》 SCIE CAS 2016年第22期5143-5153,共11页
Iran is known as an endemic country for hepatitis E virus(HEV) infection, while there are variations in the epidemiology of HEV infection throughout the country. The available epidemiological studies in different regi... Iran is known as an endemic country for hepatitis E virus(HEV) infection, while there are variations in the epidemiology of HEV infection throughout the country. The available epidemiological studies in different regions of Iran show HEV seroprevalence of 1.1%-14.2% among general population, 4.5%-14.3% among blood donors, 6.1%-22.8% among injecting drug users, 6.3%-28.3% among hemodialysis patients, 1.6%-11.3% among patients infected with other hepatitis viruses, 27.5% among patients with chronic liver disease, 30.8% among kidney transplant recipient patients, and 10%-16.4% among human immunodeficiency virus-infected patients. These variations reflect differences in the status of public health and hygiene, risk factors, and routes of transmission in different regions and groups. Therefore, it is necessary to review the epidemiology of HEV infection to determine the most prevalent risk factors and routes of transmission, and to evaluate the effectiveness of preventive strategies employed in the public health services of the country. Moreover, the other epidemiological aspects of HEV, including the genotypic pattern, extra hepatic manifestations, and incidence of chronic infection need to be investigated among Iranian population to expand the current knowledge on the epidemiology of HEV and to clarify the real burden of HEV infection. Therefore, this review was performed to provide a general overview regarding the epidemiology of HEV in Iran. 展开更多
关键词 Hepatitis E virus General population Blood donors Injecting drug users HEMODIALYSIS immunocompromised patients Chronic liver disease PREVALENCE EPIDEMIOLOGY Iran
暂未订购
Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation 被引量:1
18
作者 Arthur Dilibe Lakshmi Subramanian +6 位作者 Tracy-Ann Poyser Osejie Oriaifo Ryan Brady Sashwath Srikanth Olanrewaju Adabale Olayiwola Akeem Bolaji Hassam Ali 《World Journal of Transplantation》 2024年第2期1-7,共7页
In this editorial,we talk about a compelling case focusing on posterior reversible encephalopathy syndrome(PRES)as a complication in patients undergoing liver transplantation and treated with Tacrolimus.Tacrolimus(FK ... In this editorial,we talk about a compelling case focusing on posterior reversible encephalopathy syndrome(PRES)as a complication in patients undergoing liver transplantation and treated with Tacrolimus.Tacrolimus(FK 506),derived from Streptomyces tsukubaensis,is a potent immunosuppressive macrolide.It inhibits Tcell transcription by binding to FK-binding protein,and is able to amplify glucocorticoid and progesterone effects.Tacrolimus effectively prevents allograft rejection in transplant patients but has adverse effects such as Tacrolimus-related PRES.PRES presents with various neurological symptoms alongside elevated blood pressure,and is primarily characterized by vasogenic edema on neuroimaging.While computed tomography detects initial lesions,magnetic resonance imaging,especially the Fluid-Attenuated Inversion Recovery sequence,is superior for diagnosing cortical and subcortical edema.Our discussion centers on the incidence of PRES in solid organ transplant recipients,which ranges between 0.5 to 5+ACU-,with varying presentations,from seizures to visual disturbances.The case of a 66-year-old male status post liver transplantation highlights the diagnostic and management challenges associated with Tacrolimus-related PRES.Radiographically evident in the parietal and occipital lobes,PRES underlines the need for heightened vigilance among healthcare providers.This editorial emphasizes the importance of early recognition,accurate diagnosis,and effective management of PRES to optimize outcomes in liver transplant patients.The case further explores the balance between the efficacy of immunosuppression with Tacrolimus and its potential neurological risks,underlining the necessity for careful monitoring and intervention strategies in this patient population. 展开更多
关键词 Posterior reversible encephalopathy syndrome Liver transplantation TACROLIMUS immunocompromised patients Neurological complications Solid organ transplant
暂未订购
Fungal infections in immunocompromised critically ill patients 被引量:1
19
作者 José Garnacho-Montero Irene Barrero-García Cristina León-Moya 《Journal of Intensive Medicine》 CSCD 2024年第3期299-306,共8页
Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients wh... Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting. 展开更多
关键词 Invasive aspergillosis immunocompromised patient Critically ill patient ANTIFUNGAL Invasive candidiasis Pneumocystis jirovecii
原文传递
Crohn’s disease in human immunodeficiency virus-infected patient:A case report
20
作者 Ausra Vinikaite Benediktas Kurlinkus +5 位作者 Dominyka Jasinskaite Sandra Strainiene Audrone Buineviciute Goda Sadauskaite Vytautas Kiudelis Edita Kazenaite 《World Journal of Clinical Cases》 SCIE 2023年第17期4202-4209,共8页
BACKGROUND Inflammatory bowel disease(IBD)is an autoimmune condition treated with immunosuppressive drugs.However,the need for immune system suppression becomes questionable when infection with the human immunodeficie... BACKGROUND Inflammatory bowel disease(IBD)is an autoimmune condition treated with immunosuppressive drugs.However,the need for immune system suppression becomes questionable when infection with the human immunodeficiency virus(HIV)occurs simultaneously and impacts the course of IBD.Our reported case represents the clinical course,prescribed treatment and its effect,as well as clinical challenges faced by physicians in a combination of such diseases.We also present a comprehensive literature review of similar cases.CASE SUMMARY A 49-year-old woman suffering from a newly diagnosed Crohn’s disease was hospitalized due to exacerbated symptoms(abdominal pain,fever,and weight loss).During her hospital stay,she tested positive for HIV.With conservative treatment,the patient improved and was discharged.In the outpatient clinic,her HIV infection was confirmed as stage C3,and antiretroviral treatment was initiated immediately.That notwithstanding,soon the patient was rehospitalized with pulmonary embolism and developed a series of complications because of the subsequent coexistence of IBD and HIV.After intensive and meticulous treatment,the patient’s condition has improved and she remains in remission.CONCLUSION The paucity of studies and data on the coexistence of HIV and IBD leaves clinicians doubting the optimal treatment options. 展开更多
关键词 Crohn’s disease Inflammatory bowel disease Human immunodeficiency virus immunocompromised patient Case report
暂未订购
上一页 1 2 下一页 到第
使用帮助 返回顶部